Human Genome (HGSI) Rejects $13/Share Bid from Glaxo (GSK); Calls It 'Inadequate'
Go back to Human Genome (HGSI) Rejects $13/Share Bid from Glaxo (GSK); Calls It 'Inadequate'| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.69 -0.38 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.07 | 52 Week High | $45.58 | |||
| Open | $51.94 | 52 Week Low | $37.82 | |||
| Day High | $51.98 | P/E | N/A | |||
| Day Low | $51.38 | EPS | $0.00 | |||
| Volume | 3,982,165 | |||||
| Human Genome Sciences, Inc. (NASDAQ: HGSI) | Delayed: 14.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.24 | 52 Week High | $16.58 | |||
| Open | $55.80 | 52 Week Low | $6.51 | |||
| Day High | $14.24 | P/E | N/A | |||
| Day Low | $14.24 | EPS | $-1.79 | |||
| Volume | 557,147 | |||||
